1. June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64–73 (2018).
2. Elsallab, M., Levine, B. L., Wayne, A. S. & Abou-El-Enein, M. CAR T-cell product performance in haematological malignancies before and after marketing authorisation. Lancet Oncol. https://doi.org/10.1016/S1470-2045(19)30729-6 (2020).
3. Food and Drug Administration (FDA). Center for Biologics Evaluation and Research. Approval Letter- ABECMA. https://www.fda.gov/media/147062/download (2021).
4. Food and Drug Administration (FDA). Center for Biologics Evaluation and Research. Approval Letter-Breyanzi https://www.fda.gov/media/145712/download (2021).
5. Food and Drug Administration (FDA). Center for Biologics Evaluation and Research. Approval Letter-Yescarta. https://www.fda.gov/media/108458/download (2017).